Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Eberhard H Uhlenhuth.

Schatzberg AF, Keith SJ.

Neuropsychopharmacology. 2016 Dec;41(13):3127. doi: 10.1038/npp.2016.132. No abstract available.

PMID:
27818518
2.

Leadership experiences and characteristics of chairs of academic departments of psychiatry.

Keith SJ, Buckley PF.

Acad Psychiatry. 2011 Mar-Apr;35(2):118-21. doi: 10.1176/appi.ap.35.2.118.

PMID:
21403164
3.

Are we still talking to our patients with schizophrenia?

Keith SJ.

Am J Psychiatry. 2006 Mar;163(3):362-4. No abstract available.

PMID:
16513853
4.

Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia.

Keith SJ, Pani L, Nick B, Emsley R, San L, Turner M, Conley R, Scully P, Chue PS, Lachaux B.

Psychiatr Serv. 2004 Sep;55(9):997-1005. Review.

PMID:
15345759
5.

Ten days matter.

Keith SJ.

Psychiatr Serv. 2004 Aug;55(8):857. No abstract available.

PMID:
15292532
6.

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics.

Keith SJ, Kane JM, Turner M, Conley RR, Nasrallah HA.

J Clin Psychiatry. 2004 Jan;65(1):120-31. No abstract available.

PMID:
14744181
7.

Partial compliance and patient consequences in schizophrenia: our patients can do better.

Keith SJ, Kane JM.

J Clin Psychiatry. 2003 Nov;64(11):1308-15. Review.

PMID:
14658944
8.

Integrated treatment of schizophrenia.

Lenroot R, Bustillo JR, Lauriello J, Keith SJ.

Psychiatr Serv. 2003 Nov;54(11):1499-507. Review.

PMID:
14600309
9.

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.

Kane JM, Eerdekens M, Lindenmayer JP, Keith SJ, Lesem M, Karcher K.

Am J Psychiatry. 2003 Jun;160(6):1125-32.

PMID:
12777271

Supplemental Content

Loading ...
Support Center